Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.
Neuropharmacology
; 123: 22-33, 2017 Sep 01.
Article
in En
| MEDLINE
| ID: mdl-28526609
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Benserazide
/
Levodopa
/
Colon
/
Parkinsonian Disorders
/
Inflammation
/
Antiparkinson Agents
Limits:
Animals
Language:
En
Journal:
Neuropharmacology
Year:
2017
Document type:
Article
Affiliation country:
Country of publication: